Roche’s Phase III trial of Gazyva/Gazyvaro for SLE meets primary endpoint - Clinical Trials Arena
#Phase III#III trial#Clinical Trials#Trials Arena#SLE meets
Life Science News
Latest updates from the biotech and pharma world
Roche Piles $55M Into Blood-Brain Barrier Tech With Manifold - BioSpace
#Barrier Tech#Roche Piles#Blood-Brain Barrier#Piles#Manifold BioSpace
Roche's Gazyva, on an autoimmune hot streak, looks to further its new foothold in lupus with phase 3 win - Fierce Pharma
#Roche Gazyva#Fierce Pharma#hot streak#autoimmune hot#Pharma Roche
Roche signs $2B pact to pilot Manifold Bio's shuttles to the brain - Fierce Biotech
#Manifold Bio#Fierce Biotech#pilot Manifold#Bio shuttles#Roche signs
Roche taps an AI specialist to craft new brain drugs - BioPharma Dive
#Roche taps#BioPharma Dive#Dive Roche#brain drugs#Dive
Manifold Bio Announces Strategic Collaboration with Roche to Develop Multiple Next-Generation Brain Shuttles for Neurological Diseases - Business Wire
#Bio Announces#Announces Strategic#Strategic Collaboration#Develop Multiple#Brain Shuttles
Is Roche a Hidden Gem After Its New Immunotherapy Partnerships and Share Price Dip? - Yahoo Finance
#Price Dip#Hidden Gem#Immunotherapy Partnerships#Share Price#Yahoo Finance
Julie Roche named 2025 Fellow of the American Physical Society - Ohio University
#American Physical#Roche named#Physical Society#Ohio University#Julie Roche
Roche pens $1B biobucks deal for Chinese company's respiratory disease bispecific - Fierce Biotech
#Fierce Biotech#Chinese company#Roche pens#biobucks deal#company respiratory
Roche Earnings: We’re Slightly Lowering Our 2025 Sales Forecast but Encouraged by Diverse Pipeline - Morningstar Canada
#Sales Forecast#Slightly Lowering#Roche Earnings#Diverse Pipeline#Morningstar Canada
Executive Insights: What’s Next For Roche? - DCAT Value Chain Insights
Roche axes 4 Chugai solid tumor assets in early-phase clear-out - Fierce Biotech
#Chugai solid#Fierce Biotech#Roche axes#solid tumor#tumor assets
China pricing pressure continues to weigh on Roche's diagnostics business - Fierce Biotech
#Fierce Biotech#Roche diagnostics#China pricing#pricing pressure#pressure continues
Roche contends with loss of momentum for key medicines, currency fluctuations in Q3 but keeps growth on track - Fierce Pharma
#Fierce Pharma#key medicines#currency fluctuations#Roche contends#Pharma Roche
Roche in ongoing discussions with US government over drug pricing, CEO says - Pharmaceutical Technology
#Pharmaceutical Technology#drug pricing#ongoing discussions#Technology Roche#CEO
Roche shares fall as new drug sales disappoint - Reuters
#Roche shares#shares fall#drug sales#sales disappoint#Reuters Roche
10x, Roche, Prognosys Sue Illumina over Spatial and Single-Cell Patents - GEN - Genetic Engineering and Biotechnology News
#Prognosys Sue#Genetic Engineering#Sue Illumina#Single-Cell Patents#Patents GEN
Roche Inks Another China ADC Pact With $1.5B Hansoh Bet - BioSpace
#Hansoh Bet#China ADC#ADC Pact#Roche Inks#Hansoh
Roche to sell flu pill for $50 to cash-paying US patients - Reuters
#sell flu#flu pill#Reuters Roche#patients Reuters#Reuters
Roche Sets Gene-Sequencing Record. It’s a Challenge for Illumina. - Barron's
#Gene-Sequencing Record#Roche Sets#Sets Gene-Sequencing#Record#Illumina